Literature DB >> 27076585

Real-life assessment of the multidimensional nature of dyspnoea in COPD outpatients.

Capucine Morélot-Panzini1, Hélène Gilet2, Bernard Aguilaniu3, Philippe Devillier4, Alain Didier5, Thierry Perez6, Christophe Pignier7, Benoit Arnould2, Thomas Similowski8.   

Abstract

Dyspnoea is a prominent symptom of chronic obstructive pulmonary disease (COPD). Recent multidimensional dyspnoea questionnaires like the Multidimensional Dyspnea Profile (MDP) individualise the sensory and affective dimensions of dyspnoea. We tested the MDP in COPD outpatients based on the hypothesis that the importance of the affective dimension of dyspnoea would vary according to clinical characteristics.A multicentre, prospective, observational, real-life study was conducted in 276 patients. MDP data were compared across various categories of patients (modified Medical Research Council (mMRC) dyspnoea score, COPD Assessment Test (CAT) score, Global Initiative for Chronic Obstructive Lung Disease (GOLD) airflow obstruction categories, GOLD "ABCD" categories, and Hospital Anxiety and Depression Scale (HADS)). Univariate and multivariate regressions were conducted to explore factors influencing the affective dimension of dyspnoea. Cluster analysis was conducted to create homogeneous patient profiles.The MDP identified a more marked affective dimension of dyspnoea with more severe mMRC, CAT, 12-item Short-Form Health Survey mental component, airflow obstruction and HADS. Multivariate analysis identified airflow obstruction, depressive symptoms and physical activity as determinants of the affective dimension of dyspnoea. Patients clustered into an "elderly, ex-smoker, severe disease, no rehabilitation" group exhibited the most marked affective dimension of dyspnoea.An affective/emotional dimension of dyspnoea can be identified in routine clinical practice. It can contribute to the phenotypic description of patients. Studies are needed to determine whether targeted therapeutic interventions can be designed and whether they are useful.
Copyright ©ERS 2016.

Entities:  

Mesh:

Year:  2016        PMID: 27076585     DOI: 10.1183/13993003.01998-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  18 in total

1.  Does Nutritional Risk Screening 2002 Correlate with the Dyspnea Status of Patients with GOLD Stage C-D Chronic Obstructive Pulmonary Disease?

Authors:  Nalan Ogan; Fatma Yıldırım; Banu Süzen; Ayşe Baha; Evrim Eylem Akpınar
Journal:  Turk Thorac J       Date:  2020-01-01

2.  A Multidimensional Profile of Dyspnea in Hospitalized Patients.

Authors:  Jennifer P Stevens; Andrew R Sheridan; Heather B Bernstein; Kathy Baker; Robert W Lansing; Richard M Schwartzstein; Robert B Banzett
Journal:  Chest       Date:  2019-05-22       Impact factor: 9.410

3.  Controlled Delivery of 80 mg Aerosol Furosemide Does Not Achieve Consistent Dyspnea Relief in Patients.

Authors:  Robert W Hallowell; Richard Schwartzstein; Carl R O'Donnell; Andrew Sheridan; Robert B Banzett
Journal:  Lung       Date:  2019-11-15       Impact factor: 2.584

4.  Measuring dyspnoea: new multidimensional instruments to match our 21st century understanding.

Authors:  Robert B Banzett; Shakeeb H Moosavi
Journal:  Eur Respir J       Date:  2017-03-02       Impact factor: 16.671

5.  Swedish translation and linguistic validation of the multidimensional dyspnoea profile.

Authors:  Magnus Ekström; Josefin Sundh
Journal:  Eur Clin Respir J       Date:  2016-11-08

6.  Dyspnoea-12: a translation and linguistic validation study in a Swedish setting.

Authors:  Josefin Sundh; Magnus Ekström
Journal:  BMJ Open       Date:  2017-06-06       Impact factor: 2.692

Review 7.  European Respiratory Society International Congress 2018: Allied Respiratory Professionals' report of highlighted sessions.

Authors:  Matthew Rutter; Carlos Augusto Camillo; Peter Coss; Andreja Sajnic; Aisling McGowan; Daniel Langer; Jana De Brandt; Christian Osadnik
Journal:  ERJ Open Res       Date:  2019-02-01

8.  A breath of fresh air: Validity and reliability of a Portuguese version of the Multidimensional Dyspnea Profile for patients with COPD.

Authors:  Letícia F Belo; Antenor Rodrigues; Ana Paula Vicentin; Thaís Paes; Larissa Araújo de Castro; Nidia A Hernandes; Fabio Pitta
Journal:  PLoS One       Date:  2019-04-30       Impact factor: 3.240

9.  Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease.

Authors:  Magnus Ekström; Hans Bornefalk; Magnus Sköld; Christer Janson; Anders Blomberg; Jacob Sandberg; Anna Bornefalk-Hermansson; Helena Igelström; Josefin Sundh
Journal:  BMJ Open Respir Res       Date:  2019-09-18

10.  Interferences between breathing, experimental dyspnoea and bodily self-consciousness.

Authors:  Etienne Allard; Elisa Canzoneri; Dan Adler; Capucine Morélot-Panzini; Javier Bello-Ruiz; Bruno Herbelin; Olaf Blanke; Thomas Similowski
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.